Morris Capital Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,586
Closed -$281K 63
2020
Q1
$281K Sell
1,586
-37
-2% -$6.97K 0.3% 52
2019
Q4
$310K Sell
1,623
-38
-2% -$6.86K 0.26% 57
2019
Q3
$280K Hold
1,661
0.25% 55
2019
Q2
$278K Hold
1,661
0.23% 57
2019
Q1
$243K Sell
1,661
-8
-0.5% -$1.16K 0.19% 56
2018
Q4
$223K Sell
1,669
-57
-3% -$9.34K 0.19% 60
2018
Q3
$329K Sell
1,726
-37
-2% -$6.8K 0.22% 57
2018
Q2
$294K Sell
1,763
-4
-0.2% -$642 0.21% 58
2018
Q1
$297K Sell
1,767
-657
-27% -$110K 0.2% 58
2017
Q4
$397K Sell
2,424
-2
-0.1% -$359 0.26% 56
2017
Q3
$497K Buy
2,426
+10
+0.4% +$2.33K 0.33% 50
2017
Q2
$587K Sell
2,416
-5
-0.2% -$1.18K 0.41% 37
2017
Q1
$578K Sell
2,421
-17
-0.7% -$3.96K 0.42% 38
2016
Q4
$512K Sell
2,438
-2
-0.1% -$414 0.36% 42
2016
Q3
$562K Sell
2,440
-68
-3% -$16.6K 0.35% 35
2016
Q2
$580K Buy
2,508
+632
+34% +$146K 0.34% 36
2016
Q1
$503K Buy
1,876
+192
+11% +$55K 0.34% 41
2015
Q4
$526K Buy
+1,684
New +$501K 0.37% 40

Other funds holding AGN

Morris Capital Advisors's AGN Position: Q2 2020 in Review

Morris Capital Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,586 shares — an estimated $281K sold.

Morris Capital Advisors first reported a position in AGN in Q4 2015 and held it in 18 quarters. The position peaked at $587K in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Morris Capital Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Morris Capital Advisors sold 1,586 Allergan plc shares in Q2 2020, an estimated $281K.
  • Morris Capital Advisors first reported a position in Allergan plc in Q4 2015 and held it in 18 quarters.
  • Morris Capital Advisors's Allergan plc position peaked at $587K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Morris Capital Advisors's 13F filing for Q2 2020, filed 23 Jul 2020.